DBPR728
Product Specifications
CAS Number
2702965-64-6
Target
Aurora Kinase
Related Pathways
Chromatin/Epigenetic, Cell Cycle/Checkpoint
Bioactivity
DBPR728, an acyl prodrug of 6K465, possesses fewer hydrogen bond donors and functions as an Aurora kinase inhibitor that targets MYC family cancer proteins, showing antitumor potential. It can effectively inhibit cancers overexpressing C-MYC and N-MYC, offering a 10-fold improvement in oral bioavailability over 6K465.
Smiles
O=C(C=1C=CC=C(Cl)C1F)N2CCC(NC=3N=C(C=C(N3)N4CCN(CC)CC4)NC5=CC(=NN5C(=O)CC)C)CC2
Molecular Formula
C29H37ClFN9O2
Molecular Weight
598.11
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRV-0020250-01 50 Tests
Anti-Cluster Of Differentiation 200 (CD200) Polyclonal Antibody
Sign In for Pricing
View Details TRV-0020250-02 100 Tests
Anti-Cluster Of Differentiation 200 (CD200) Polyclonal Antibody
Sign In for Pricing
View Details TRV-0020250-03 200 Tests
Anti-Cluster Of Differentiation 200 (CD200) Polyclonal Antibody
Sign In for Pricing
View Details 